Financials data is unavailable for this security.
View more
Year on year Ypsomed Holding AG grew revenues 10.25% from 497.46m to 548.46m. In addition the company has reduced the cost of goods sold as a percent of sales, selling, general and administrative expenses as a percent of sales and interest paid as a percent of sales. These improvements contributed to 52.83% net income growth from 51.28m to 78.37m.
| Gross margin | 35.44% |
|---|---|
| Net profit margin | 12.06% |
| Operating margin | 14.07% |
| Return on assets | 7.03% |
|---|---|
| Return on equity | 12.44% |
| Return on investment | 11.60% |
More ▼
Cash flow in CHFView more
In 2024, Ypsomed Holding AG increased its cash reserves by 193.44%, or 48.79m. The company earned 163.22m from its operations for a Cash Flow Margin of 29.76%. In addition the company generated 81.07m cash from financing while 195.07m was spent on investing.
| Cash flow per share | 11.05 |
|---|---|
| Price/Cash flow per share | 31.48 |
| Book value per share | 45.56 |
|---|---|
| Tangible book value per share | 23.19 |
More ▼
Balance sheet in CHFView more
| Current ratio | 0.6645 |
|---|---|
| Quick ratio | 0.5060 |
| Total debt/total equity | 0.5229 |
|---|---|
| Total debt/total capital | 0.3434 |
More ▼
Growth rates in CHF
Year on year, both dividends per share and earnings per share excluding extraordinary items growth increased 53.85% and 50.26%, respectively. The positive trend in dividend payments is noteworthy since very few companies in the Medical Equipment & Supplies industry pay a dividend. Additionally when measured on a five year annualized basis, dividend per share growth ranked highest relative to its industry peers, while earnings per share growth is in-line with the industry average.
| Div yield(5 year avg) | 0.53% |
|---|---|
| Div growth rate (5 year) | 29.46% |
| Payout ratio (TTM) | 18.35% |
| EPS growth(5 years) | 3.77 |
|---|---|
| EPS (TTM) vs TTM 1 year ago | 2.58 |
More ▼
